Navigation Links
New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)

UPPSALA, Sweden and CAMBRIDGE, England, April 23 /PRNewswire/ -- Two leading companies in the area of fragment-based drug discovery (FBDD) today announced a new commercial alliance. IOTA Pharmaceuticals Ltd, based in Cambridge, UK, and Beactica AB, based in Uppsala, Sweden, will join forces to deploy a proprietary FBDD-based lead discovery and optimization platform.

The IOTA-Beactica platform couples comprehensive, site-directed FBDD libraries to state-of-the-art fragment and lead screening using surface plasmon resonance (SPR) biosensor technology, enabling the rapid progression of new discovery programs from concept to optimized lead.

Based on rapid determination of ligand-target interaction information, and using a unique combination of fragment-based drug screening and medicinal chemistry-led design approaches, applicable to a wide range of new targets, the platform will initially focus on the development of new classes of kinase inhibitors. The reagents, tools and technologies developed by the two companies will be commercialized through drug discovery partnerships with pharmaceutical companies active in the kinase area.

Dr Per Kallblad, CEO of Beactica, said, "We are delighted to work with IOTA to expand our existing drug discovery platform. The combination of IOTA's proprietary FBDD engine with Beactica's SPR screening technology will be an excellent way to pursue the discovery and optimization of new kinase inhibitors."

Dr David Bailey, heading IOTA, commented, "Fragment-based drug discovery is a fast, efficient and productive route to NCE discovery. Our combined technologies offer a comprehensive lead discovery solution to our pharma partners."

About IOTA

IOTA Pharmaceuticals provides FBDD-based molecular design, compound screening and lead discovery services to its partners in the pharmaceutical industry. For more information about IOTA, please visit

About Beactica

Beactica is a specialist drug discovery company, utilizing its proprietary methodologies to evaluate the biophysical interaction of molecules in order to generate novel therapeutics. For more information about Beactica, please visit


Dr David Bailey, CEO IOTA

Dr Per Kallblad, CEO Beactica

SOURCE IOTA Pharmaceuticals Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress
2. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
3. Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
4. Progen Restructures Manufacturing and Drug Discovery Divisions
5. Sigma-Aldrich Partners With Sunset Molecular Discovery to Expand Your Favorite Gene Search Tool
6. Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery
7. Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts
8. BioCrossroads Launches and Releases Report on Biopharma Discovery and Development Contract Services
9. European Company NovaSecta Joins First Chinese CRO Service Alliance for Drug Discovery Solutions
10. Contract Services for Big Pharma and Biotechs Driving Growth and Innovation from Discovery to Clinical Trials
11. Xenon Announces Appointment of VP, Discovery Research
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  The ALS Association, in ... Assistive Technology Challenge to revolutionize communication technology solutions for ... --> ALS (amyotrophic lateral sclerosis) is a ... the brain and the spinal cord. Eventually, people with ... movement, which often leads to total paralysis and death ...
(Date:10/8/2015)...  Sigma-Aldrich Corporation (NASDAQ: SIAL ) announced ... its Applied Diagnostics and Testing business segment has ... line with ten certified Snap-N-Spike ® solutions ... their stable-labeled internal standards. These new solution certified ... acid and native and deuterium-labeled analogs of cholic ...
(Date:10/8/2015)... ... October 08, 2015 , ... ... fibrosis transmembrane conductance regulator (CFTR) gene and results in dysfunction of the lungs ... accumulates in the lungs. This mucus is very difficult to clear, blocks the ...
(Date:10/7/2015)... ... 2015 , ... Neil Riordan, PhD to Discuss Medicinal Effects of Mesenchymal Stem ... from 3:50 pm to 4:30 pm. , Dr. Riordan is one of the early ... is the Co-Founder and Chief Science Officer of the Riordan-McKenna Institute of ...
Breaking Biology Technology:
... and provides ... content not found elsewhere, MILFORD, Mass., Nov. 3 ... debut of an online community,designed to support the success of ... UltraPerformance,LC(R) (UPLC) System users worldwide, membership in this new online,community ...
... Neb. and GUELPH, Ontario, Nov. 3 ... an agreement to,distribute LI-COR biotechnology products in ... the local presence of Mandel Scientific skilled ... greatly enhance our ability to serve,our Canadian ...
... Albert Liou, Corporate Vice,President and General Manager, Asia-Pacific ... a leading global,biopharmaceutical services provider, will present "What ... Efficiency Savings in Running Clinical,Trials?" at the 7th ... be held November 4 - 7, 2008 at ...
Cached Biology Technology:
(Date:9/28/2015)... , September 28, 2015 The ... to reach USD 12.03 billion by 2020, growing at ... advancements such as Backside Illumination (BSI) technique to improve ... the forecast period.      (Logo: , ... the chip to reduce loss and, thus, reduce the ...
(Date:9/24/2015)... 24, 2015  EyeLock LLC, a market leader of ... winning and latest technology in Booth #602 at next ... . EyeLock,s iris authentication technology provides an ... accuracy, making it the most proven way to authenticate ... technology to deliver a fast and friendly user experience ...
(Date:9/10/2015)... , Sept. 10, 2015 Report Details ... not quite delivered upon previous expectations of revenues, consumer ... the breakthrough year in which wearables begin to achieve ... One of the main reasons is the entrance of ... only the SmartWatches market, but the overall size of ...
Breaking Biology News(10 mins):
... Care through Bio and Information Standards and Technologies, a ... standards can play in helping the United States manage ... technology investments should be made to enhance health care ... WHEN: Tuesday 25 September, 8:30 a.m. to 5:30 ...
... in French . , Vancouver, B.C. - ... Natural Resources will speak at the UBCM Pine Beetle ... under the Mountain Pine Beetle Program to help affected ... Hotel, Mackenzie Room, 900 Canada Place Way, Vancouver, B.C. ...
... counselling on diet and lifestyle offers significant benefits to ... University Technology research. Dietitian Katrina Campbell, who graduated ... 62 pre-dialysis patients at the Royal Brisbane and Women,s ... part of her thesis. Dr Campbell said depending ...
Cached Biology News:
... Grade Thrombin is a highly purified preparation ... with appropriate vectors. The preparation is functionally ... is free of detectable contaminating proteases. Prepared ... by certified tests to be negative for ...
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
Rat Aortic Smooth Muscle Cells (RAOSMC) (>500,000 cells)...
Biology Products: